Company Data
Spyre Therapeutics Inc.
Ticker
SYRE
Current Price
$86.955 -2.66%
Market Cap
$7.7B
Price Target
Refer to Report
Volume
312.8K
52wk Range
$14.505 - $110.175
Overview
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company’s lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.